BRIEF published on 09/29/2025 at 23:05, 4 months 1 day ago GenSight Biologics annonce ses résultats financiers du premier semestre 2025 Résultats Financiers Recherche Et Développement Trésorerie GenSight Biologics Programmes D'accès Précoce
PRESS RELEASE published on 09/29/2025 at 23:00, 4 months 1 day ago Inside Information / News release on accounts, results GenSight Biologics reports 8.3% reduction in operating cash outflow and extends cash runway to late Q4 2025. Company's financial results show decrease in operating income, R&D expenses, and net cash flows Financial Results Operating Income Cash Management GenSight Biologics R&D Expenses
PRESS RELEASE published on 09/29/2025 at 23:00, 4 months 1 day ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie résultats financiers du premier semestre 2025 : gestion optimisée de trésorerie, financement post-clôture, transfert de fabrication, protocole d'étude soumis à l'ANSM Résultats Financiers Financement Trésorerie GenSight Biologics Étude ANSM
BRIEF published on 08/28/2025 at 20:05, 5 months 3 days ago GenSight Biologics Delays 2025 Half-Year Financial Results Announcement Financial Results Regulatory Compliance Postponement GenSight Biologics Audit Procedures
BRIEF published on 08/28/2025 at 20:05, 5 months 3 days ago GenSight Biologics reporte la publication de ses résultats financiers semestriels 2025 Résultats Financiers Conformité Réglementaire Report GenSight Biologics Procédures D'audit
PRESS RELEASE published on 08/28/2025 at 20:00, 5 months 3 days ago Inside Information / Other news releases GenSight Biologics postpones the release of its 2025 half-year financial results to September 29, 2025, after the market closes, to ensure highest audit standards. No material issues reported. Audit Committee and Board meetings rescheduled Financial Results Transparency Postponement GenSight Biologics Audit Procedures
PRESS RELEASE published on 08/28/2025 at 20:00, 5 months 3 days ago Informations privilégiées / Autres communiqués GenSight Biologics reporte la publication de ses résultats financiers semestriels 2025. Le report est dû à l'audit en cours, non lié à des problèmes financiers. Réunions importantes reprogrammées Résultats Financiers Communication Financière Audit Report GenSight Biologics
BRIEF published on 07/17/2025 at 15:05, 6 months 14 days ago GenSight Biologics: Publication of an article on the predictions of LUMEVOQ® gene therapy Gene Therapy GenSight Biologics NOHL LUMEVOQ Visual Acuity
BRIEF published on 07/17/2025 at 15:05, 6 months 14 days ago GenSight Biologics : publication d'un article sur les prédictions de la thérapie génique LUMEVOQ® Thérapie Génique GenSight Biologics NOHL LUMEVOQ Acuité Visuelle
Published on 01/31/2026 at 03:15, 1 day 9 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 10 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 13 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 01/31/2026 at 15:54, 20 hours 32 minutes ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 9 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 14 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 16 hours ago Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026
Published on 01/30/2026 at 18:40, 1 day 17 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 1 day 18 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 18 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 3 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
